loader image

Kelso Pharma closes acquisition of Italian specialty pharma company, Velit Biopharma

The acquisition of Italian specialty pharma company, Velit Biopharma (Velit), by UK-based specialty pharma business, Kelso Pharma (Kelso), announced on 13th November 2023, has now closed. This is the first step for Kelso in its European expansion strategy and Velit is now part of the Kelso group of companies, which also includes Glasgow-based Stirling Anglian […]

Kelso Pharma announces strategic partnerships with PharmaPath and Valpharma

Kelso Pharma, the growing UK-based specialty pharma business, has concluded two new collaboration agreements with pharmaceuticals companies, PharmaPath and Valpharma. The specific products are not being disclosed at this time but the partnerships will add a new therapeutic area to the product portfolio of Kelso Pharma and its UK subsidiary, Stirling Anglian Pharmaceuticals (SAP). PharmaPath, […]

Kelso Pharma announces two UK product acquisitions as growth continues

Kelso Pharma, the growing UK-based specialty pharma business, has concluded a deal to acquire two UK approved products, representing an exciting launch into the specialty of Dermatology with prescription medicines for the treatment of actinic keratoses and plaque psoriasis. The two dermatology products, purchased from an organisation within the Dermapharm Group, represent another exciting move […]

Kelso Pharma announces first product launch

Kelso Pharma, the growing UK based specialty pharma business, has announced its first product launch with the release to the UK prescription medicines market of Acepiro® (Acetylcysteine) 600mg effervescent tablets. Acepiro (Acetylcysteine) is indicated in adults as a mucolytic agent for the treatment of respiratory tract diseases in which a reduction in bronchial secretion viscosity […]